Limax Biosciences
Student i-lab
Limax Biosciences
Treating internal and external injuries with a stretchable adhesive hydrogel.
About Limax Biosciences
Term
2023 Summer
School
Non-Harvard Affiliate, Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard Medical School
Lab
Connect
Limax Biosciences is developing a next generation, stretchable hydrogel-based tissue adhesive to revolutionize treatments for injuries inside and outside the body. Existing hemostatic dressings and sealants have weak tissue adhesion that result in leaks, tissue rigidity, and cytotoxicity. Limax’s degradable, hydrogel-based material addresses these limitations through strong and rapid adhesion to wet tissue surfaces at 10-100x higher the strength of competitors. This patent-protected platform technology can be used in several indications throughout the body including soft tissue reinforcement and local drug delivery.
Join Us
Current Harvard students: submit your spring membership form by Thursday, January 9.